Herkules, Frank
Yu, Corey H. http://orcid.org/0000-0002-1374-4194
Taylor, Alexander B. http://orcid.org/0000-0003-3517-6033
Dougherty, Vi
Weintraub, Susan T.
Ivanov, Dmitri N. http://orcid.org/0000-0002-9442-3316
Funding for this research was provided by:
Welch Foundation (AQ-1996-20190330)
Article History
Received: 10 January 2022
Accepted: 9 November 2022
First Online: 19 November 2022
Competing interests
: A pending patent application PCT/US2022/048268 lists the Board of Regents, The University of Texas System as the applicant and F.H. and D.N.I. as inventors. D.N.I. is a co-founder and a shareholder of E3 Biosciences LLC, a commercial entity that manufactures reagents described in this study for use in academic and commercial research. The remaining authors declare no other competing interests.